Ruth Cooper

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial

Ruth Cooper, Emma Williams, Seth Seegobin et al. · European Neuropsychopharmacology · 2017 · 170 citations

Medicine, Neuroscience, Pharmacology +9

Validation of the Mind Excessively Wandering Scale and the Relationship of Mind Wandering to Impairment in Adult ADHD

Florence D. Mowlem, Caroline Skirrow, Peter Reid et al. · Journal of Attention Disorders · 2016 · 158 citations · Full text

Medicine, Psychiatry, Psychology +17

Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial

Joanna Moncrieff, Nadia Crellin, Jacki Stansfeld et al. · The Lancet Psychiatry · 2023 · 86 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)

Joanna Moncrieff, Glyn Lewis, Nick Freemantle et al. · BMJ Open · 2019 · 50 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation

Ruth Cooper, Éanna Hanratty, Nicola Morant et al. · PLoS ONE · 2019 · 49 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17